IBM develops macromolecule that could counter antibiotic resistance
Team Udayavani, Jul 23, 2020, 7:11 PM IST
IBM Research team with the support of several other scientists has developed a synthetic macromolecule polymer to counter antibiotic resistance.
It can potentially be used to significantly increase the effectiveness of existing antibiotics. It works by essentially hitching itself to the enzymes that bacteria modify when they are treated using antibiotics, but not completely eliminated
Researchers claim that the polymer attaches to the cytosolic enzymes on the membrane of the pathogens.
However, the report clarified that the study is relatively early research that has been conducted in a highly controlled laboratory.
Researchers worked in partnership with Singapore’s Institute of Bioengineering and Nanotechnology
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
World COPD Day: Know your lung function
As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all
World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness
World Diabetes Day: An overview of types of diabetes
World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates
MUST WATCH
Latest Additions
Siddaramaiah says confident of winning all three bypolls in Karnataka
Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial
AIMPLB to hold its annual general sessions in Bengaluru from November 23
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.